PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

204 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
81.
Kuiper, I.N.* et al.: Lung health in adulthood after childhood exposure to air pollution and greenness. Eur. Respir. J. 52 (2018)
82.
Lambert, K.A.* et al.: Associations between early life exposure to pollen and adolescent lung function are modified by residential greenness. Eur. Respir. J. 52 (2018)
83.
Lamort, A. et al.: Tumor-derived granulocyte chemotactic protein 2 cooperates with neutrophil proteinase 3 to drive lung adenocarcinoma. Eur. Respir. J. 52 (2018)
84.
Lingner, H.* et al.: Describing "real world" COPD patients in primary care in Germany - Findings of the BeoNet-Registry. Eur. Respir. J. 52 (2018)
85.
Pekkanen, J.* et al.: Indoor bacteria and asthma in adults: A multicentre case-control study within ECRHS II. Eur. Respir. J. 51:1701241 (2018)
86.
Pepe, M. ; Pelizza, F.* ; Lamort, A. ; Kanellakis, N.I.* & Stathopoulos, G.T.: Alteration patterns of tobacco carcinogens in lung adenocarcinoma reveal novel KRAS-addicted candidate oncogenes. Eur. Respir. J. 52 (2018)
87.
Peralta, G.P.* et al.: Body mass index trajectories during adult life and lung function decline. Eur. Respir. J. 52 (2018)
88.
Real, F.G.* et al.: Maternal age at delivery, lung function and asthma in offspring: A population-based survey. Eur. Respir. J. 51:1601611 (2018)
89.
Russell, M.* et al.: The association of vigorous physical activity with 10-year adult asthma incidence. Eur. Respir. J. 52 (2018)
90.
Schroeder, A.S.* et al.: IL-37 ameliorates experimental asthma by inhibiting IL-1. Eur. Respir. J. 52 (2018)
91.
Schultz, K.* et al.: Effectiveness of pulmonary Rrhabilitation for patients with asthma: EPRA-RCT. Eur. Respir. J. 52 (2018)
92.
Schwarzkopf, L. ; Witt, S. ; Waelscher, J.* ; Polke, M.* & Kreuter, M.*: Associations between comorbidities, their treatment and survival in patients with interstitial lung diseases - a claims data analysis. Eur. Respir. J. 52 (2018)
93.
Schwarzkopf, L. & Murawski, M.: Survival impact of comorbidity in German Lung Cancer patients - a claims data-based 'Comorbidome'. Eur. Respir. J. 52 (2018)
94.
Sun, N. et al.: Pharmacometabolic response to pirfenidone in pulmonary fibrosis detected by MALDI-FTICR-MSI. Eur. Respir. J. 52:1702314 (2018)
95.
Szentes, B.L. et al.: Suitable questionnaires to measure quality of life in patients with asthma bronchial undergoing pulmonary rehabilitation. Eur. Respir. J. 52 (2018)
96.
Walter, J. ; Holle, R. ; Tufman, A.* & Schwarzkopf, L.: Changes in targeted therapy and costs in NSCLC between 2009 and 2013. Eur. Respir. J. 52 (2018)
97.
Wartenberg, M.* et al.: Cigarette smoke induces overexpression of cathepsin S in active smokers with and without COPD. Eur. Respir. J. 52 (2018)
98.
Welk, V. et al.: Analyzing the role of proteasome activator 200 (PA200) in lung cancer. Eur. Respir. J. 52 (2018)
99.
Witt, S. ; Waelscher, J.* ; Schwarzkopf, L. & Kreuter, M.*: Hospitalisation pattern in Interstitial Lung Diseases: A claims data study. Eur. Respir. J. 52 (2018)
100.
Witt, S. et al.: Medication for childhood interstitial lung diseases differs internationally. Eur. Respir. J. 52 (2018)
▮◀ ◀◀ 1 ... 2 ... 3 ... 4 ... 5 ... 6 ... 7 ... 8 ... 9 ... 10 ... 11 ... ▶▶ ▶▮